Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT05275699

Analyse of Diagnosis Value of Keloid on 68Ga- FAPI-04 PET-CT

Sponsor: Peking Union Medical College Hospital

Conditions Keloid

Interventions 68Ga-FAPI

Updated 4 times since 2022 Last updated: Jun 21, 2023 Started: Mar 1, 2022 Primary completion: Feb 1, 2023 Completion: Feb 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Keloid, this trial is completed. The trial is conducted by Peking Union Medical College Hospital and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jul 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2

Status: Recruiting → Completed · Phase: PHASE1 → PHASE1_PHASE2
Apr 2022 — Jul 2023 [monthly]

Recruiting PHASE1

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China